AMPE News and Press, Ampio Pharmaceuticals Inc. From 11/08/22

Ampio Pharmaceuticals ( OTC:AMPE ) said Tuesday it will implement a 1-for-15 reverse stock split . No fractional shares will be outstanding after the reverse split. Ampio ( OTC:AMPE ) had ~226.3M shares outstanding prior to the reverse split. The reverse stock...

Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Split PR Newswire The Reverse Stock Split Will Take Effect November 9, 2022 at 4:01 p.m. ET ENGLEWOOD, Colo. , Nov. 8, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE Amer...

Ampio Pharmaceuticals Announces NYSE American Has Commenced Delisting Proceedings PR Newswire ENGLEWOOD, Colo. , Oct. 4, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") received written notification from NYSE America...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock We’re starting Wednesday with an overview of the biggest pre-market stock movers this morning! There’s an earnings report, an upcoming reverse stock split, and more to go over this...

3 Strategies for Trading Penny Stocks in September 2022 If you’re thinking about investing in penny stocks, there’s no better time than the present. Although buying and selling penny stocks in the past few months has not been easy, there are plenty of methods to profit...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ventdusud / Shutterstock.com We’re starting the final trading day of the week with an overview of the biggest pre-market stock movers for Friday! We’ve got initial public offerings ( IPO ), a...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Ampio To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - August 23, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is...

New York, New York--(Newsfile Corp. - August 22, 2022) - Levi & Korsinsky, LLP notifies investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) of a class action securities lawsuit. The lawsuit on behalf of Ampio investors has been commenced in the the United St...

NEW YORK, NY / ACCESSWIRE / August 19, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE:AMPE) and reminds investors of the October 17, 2022 deadline to seek the role...

Ampio Pharmaceuticals ( NYSE: AMPE ), a clinical-stage company focused on osteoarthritic pain, disclosed its plans to cut its staff count by more than 50% on Wednesday after a decision to end the development of a major clinical program targeted at conditions including COVID-19...